InspireMD- Warrants EBIT

As of the most recent data (December 2025), NSPRZ shows a EBIT of $-48M. That compares with $-34M in the prior-year period — down 44.6% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NSPRZ's EBIT is now $-48M (was $-34M) — a 44.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether InspireMD- Warrants is outperforming or lagging.

The Healthcare sector average EBIT is about $110B. InspireMD- Warrants is at $-48M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how NSPRZ stacks up against individual peers as well.

Tracking NSPRZ's ebit over time shows whether InspireMD- Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $-48M That compares with $-34M in the prior-year period — down 44.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has InspireMD- Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-48M) with ownership activity and broader fundamentals.